A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry
Open Access
- 5 November 2020
- Vol. 12 (11), 1267
- https://doi.org/10.3390/v12111267
Abstract
Dengue virus (DENV) infection has become a critically important globally prevalent infectious disease, especially in tropical and subtropical countries. Since neither currently exists, there is an urgent need for an effective vaccine to prevent, and a specific drug to treat DENV infection. Therapeutic peptides represent an attractive alternative for development into anti-DENV drugs due to their safety and their diverse biological and chemical properties. We recently reported novel bioactive peptides extracted from the Asian medicinal plant Acacia catechu that efficiently inhibited all four DENV serotypes. In this study, we investigated the anti-DENV activity of a synthetic bioactive peptide derived from this plant. The most effective peptide (designated Pep-RTYM) inhibited DENV infection with a half-maximal inhibition concentration value of 7.9 μM. Time-of-addition study demonstrated that Pep-RTYM interacted with DENV particles and inhibited cellular entry. Pep-RTYM at 50 μM significantly reduced DENV production in Vero-kidney epithelial cells about 1000-fold, but it could decrease the virus production in Huh7 hepatocyte cells approximately 40-fold. Binding of Pep-RTYM to DENV particles may prevent virus interaction with cellular receptor and subsequent virus entry. This finding suggests a potential role of Pep-RTYM in the development of a novel anti-DENV drug.Keywords
This publication has 33 references indexed in Scilit:
- Improved Protease Stability of the Antimicrobial Peptide Pin2 Substituted with d-Amino AcidsJournal of Protein Chemistry, 2013
- Dengue viruses – an overviewInfection Ecology & Epidemiology, 2013
- Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral PeptidesInternational Journal of Medical Sciences, 2013
- Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide AnalogsPLOS ONE, 2010
- Easy Strategy To Protect Antimicrobial Peptides from Fast Degradation in SerumAntimicrobial Agents and Chemotherapy, 2010
- Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesJournal of Virology, 2007
- Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flavivirusesAntiviral Research, 2006
- The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cellAntiviral Research, 2005
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000
- Development and validation of a genetic algorithm for flexible dockingJournal of Molecular Biology, 1997